4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006728
SVP, Chief Financial Officer acquired 96,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coiante Scott M SVP, Chief Financial Officer | 2021-02-25 | Grant or award | +33,000 | 35,500 | D | ||
| Coiante Scott M SVP, Chief Financial Officer | 2021-02-25 | Grant or award | +63,500 | 99,000 | D | ||
| Derivatives | |||||||
| Coiante Scott M SVP, Chief Financial Officer | 2021-02-25 | Grant or award · Stock Option (right to Buy) | +143,000 | 143,000 | D | ||
Loading xslF345X03/form4.xml…